While much of the recent buzz around AI has focused on its ability to create captivating digital content from simple prompts and the potential negative impact on the workforce and spread of misinformation, there is a more promising side to AI in the field of medicine. Google’s AlphaFold software has received an update that could pave the way for significant advancements in disease research and treatment.
Developed by Google DeepMind and Isomorphic Labs (both owned by Alphabet), AlphaFold has proven its ability to accurately predict how proteins fold. With a database of 200 million known proteins, millions of researchers have utilized previous versions of the software to make breakthroughs in areas such as malaria vaccines, cancer treatment, and enzyme designs.
Understanding the shape and structure of proteins is crucial in developing new drugs and enhancing existing ones, as it determines how they interact with the human body…
2024-05-08 14:47:26
Source from www.engadget.com